Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

about

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

Item

http://www.wikidata.org/entity/Q44548929

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

@en

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

@nl

type

Item

label

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

@en

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

@nl

prefLabel

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

@en

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

@nl

P1476

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

@en

P2093

Thomas F Whayne

http://www.w3.org/2001/XMLSchema#string

P2860

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.

Effects of drugs on uric acid in man.

Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis.

Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Niacin in cardiovascular disease: recent preclinical and clinical developments

P304

557-559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1177/0003319713505897

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257531410

http://www.w3.org/2001/XMLSchema#string

P698

24101713

http://www.w3.org/2001/XMLSchema#string